Dipan Mehta of Elixir Equities offers a selective outlook, favoring NBFCs and pharma while cautioning on metals and avoiding certain largecaps. He sees strength in diversified NBFCs and potential in solar despite current underperformance, but advises patience…
In a conversation with ET Now, Dipan Mehta, Director, Elixir Equities shared a constructive but selective outlook across sectors, expressing optimism on NBFCs and pharma, caution on metals, and a cle… [+4014 chars]
